Microstructural Brain Development and Neurodevelopmental Outcome of Very Preterm Infants of Mothers with Gestational Diabetes Mellitus.


Journal

Neonatology
ISSN: 1661-7819
Titre abrégé: Neonatology
Pays: Switzerland
ID NLM: 101286577

Informations de publication

Date de publication:
2023
Historique:
received: 17 05 2023
accepted: 21 07 2023
medline: 11 12 2023
pubmed: 30 8 2023
entrez: 29 8 2023
Statut: ppublish

Résumé

There are data linking gestational diabetes mellitus (GDM) with adverse neurodevelopmental outcome in the offspring. We investigated the effect of GDM on microstructural brain development and neurodevelopmental outcome of very preterm infants. Preterm infants <32 gestational weeks of mothers with GDM obtained cerebral magnetic resonance imaging (MRI) including diffusion-tensor imaging at term-equivalent age. For every infant, two gestational age-, sex-, and MRI scanner type-matched controls were included. Brain injury was assessed and fractional anisotropy (FA) and apparent diffusion coefficient (ADC) measured in 14 defined cerebral regions. Neurodevelopmental outcome was quantified at the corrected age of 24 months using the Bayley Scales of Infant Development. We included 47 infants of mothers with GDM and 94 controls. There were no differences in neonatal morbidity between the groups, nor in any type of brain injury. The GDM group showed significantly higher FA values in the centrum semiovale, the posterior limb of the internal capsule and the pons bilaterally, in the corpus callosum and the right occipital white matter, as well as lower ADC values in the right centrum semiovale, the right occipital white matter and the corpus callosum. Neurodevelopmental outcome did not differ between the groups. We found no impairment of brain development in GDM-exposed infants compared to matched controls, but differences in white matter microstructure in specific regions indicating an enhanced maturation. However, neurodevelopmental outcome was equal in both groups. Further studies are needed to better understand brain maturation in preterm infants exposed to GDM.

Identifiants

pubmed: 37643585
pii: 000533335
doi: 10.1159/000533335
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

768-775

Informations de copyright

© 2023 The Author(s). Published by S. Karger AG, Basel.

Auteurs

Maria Sappler (M)

Department of Pediatrics II, Neonatology, Medical University of Innsbruck, Innsbruck, Austria, Maria.Sappler@i-med.ac.at.

Nina Volleritsch (N)

Department of Pediatrics II, Neonatology, Medical University of Innsbruck, Innsbruck, Austria.

Marlene Hammerl (M)

Department of Pediatrics II, Neonatology, Medical University of Innsbruck, Innsbruck, Austria.

Yasmin Pellkofer (Y)

Department of Pediatrics II, Neonatology, Medical University of Innsbruck, Innsbruck, Austria.

Elke Griesmaier (E)

Department of Pediatrics II, Neonatology, Medical University of Innsbruck, Innsbruck, Austria.

Elke Ruth Gizewski (ER)

Department of Neuroradiology, Medical University of Innsbruck, Innsbruck, Austria.
Neuroimaging Research Core Facility, Medical University of Innsbruck, Innsbruck, Austria.

Susanne Kaser (S)

Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria.

Ursula Kiechl-Kohlendorfer (U)

Department of Pediatrics II, Neonatology, Medical University of Innsbruck, Innsbruck, Austria.

Vera Neubauer (V)

Department of Pediatrics II, Neonatology, Medical University of Innsbruck, Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH